Advertisement

The Cerebellum

, Volume 6, Issue 2, pp 118–122 | Cite as

Clinical, biochemical and molecular aspects of cerebellar ataxia and Coenzyme Q10 deficiency

  • Raquel Montero
  • Mercé Pineda
  • Asun Aracil
  • Maria-Antonia Vilaseca
  • Paz Briones
  • José-Antonio Sánchez-Alcázar
  • Plácido Navas
  • Rafael ArtuchEmail author
Mini-Review Scientific Papers

Abstract

Coenzyme Q10 (CoQ) deficiency is an autosomal recessive disorder presenting five phenotypes: a myopathic form, a severe infantile neurological syndrome associated with nephritic syndrome, an ataxic variant, Leigh syndrome and a pure myopathic form. The third is the most common phenotype related with CoQ deficiency and it will be the focus of this review. This new syndrome presents muscle CoQ deficiency associated with cerebellar ataxia and cerebellar atrophy as the main neurological signs. Biochemically, the hallmark of CoQ deficiency syndrome is a decreased CoQ concentration in muscle and/or fibroblasts. There is no molecular evidence of the enzyme or gene involved in primary CoQ deficiencies associated with cerebellar ataxia, although recently a family has been reported with mutations atCOQ2 gene who present a distinct phenotype. Patients with primary CoQ deficiency may benefit from CoQ supplementation, although the clinical response to this therapy varies even among patients with similar phenotypes. Some present an excellent response to CoQ while others show only a partial improvement of some symptoms and signs. CoQ deficiency is the mitochondrial encephalomyopathy with the best clinical response to CoQ supplementation, highlighting the importance of an early identification of this disorder.

Key words

Cerebellum ataxia coenzyme Q10 deficiency mitochondrial respiratory chain 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Crane FL, Hatefi Y, Lester RL, Widmer C. Isolation of a quinone from beef heart mitochondria. Biochim Biophys Acta. 1957;25:220-l.PubMedCrossRefGoogle Scholar
  2. 2.
    Santos-Ocana C, Villalba JM, Cordoba F, Padilla S, Crane FL, Clarke CF, Navas P. Genetic evidence for coenzyme Q requirement in plasma membrane electron transport. J Bioenerg Biomembr. 1998;30:465–75.PubMedCrossRefGoogle Scholar
  3. 3.
    Kagan VE, Arroyo A, Tyurin VA, Tyurina YY, Villalba JM, Navas P. Plasma membrane NADH-coenzyme QO reductase generates semiquinone radicals and recycles vitamin E homologue in a superoxide-dependent reaction. FEBS Lett. 1998 22;428:43–6.CrossRefGoogle Scholar
  4. 4.
    Villalba JM, Navarro F, Cordoba F, Serrano A, Arroyo A, Crane FL, Navas P. Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport. Proc Natl Acad Sci USA. 1995;92: 4887–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta. 1995;1271:195–202.PubMedGoogle Scholar
  6. 6.
    Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, DiMauro S, Hirano M. A mutation inPara- Hydroxybenzoate-Polyprenyl Transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet. 2006;78:345–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Hubner C, Hoffmann GF, Charpentier C, Gibson KM, Finckh B, Puhl H, Lehr HA, Kohlschutter A. Decreased plasma ubiquinone-10 concentration in patients with mevalonate kinase deficiency. Pediatr Res. 1993;34:129–33.PubMedCrossRefGoogle Scholar
  8. 8.
    Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, Broccolini A, Tonali P, Di Mauro S, Servidei S. Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial Q10 deficiency. Neurology. 2001;57: 515–8.PubMedGoogle Scholar
  9. 9.
    Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA. 1989;86:2379–82.PubMedCrossRefGoogle Scholar
  10. 10.
    Rötig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, Edery P, Lebideau M, Dallner G, Munnich A, Ernster L, Rustin P. Quinone-responsive multiple respiratory chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet. 2000;356:391–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Rahman S, Hargreaves I, Clayton P, Heales S. Neonatal presentation of coenzyme Q10 deficiency. J Pediatr. 2001; 139:456–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Musumeci O, Naini A, Slonim AE, Skavin N, Hadjigeorgiou GL, Krawiecki N, Weissman BM, Tsao CY, Mendell JR, Shanske S, De Vivo DC, Hirano M, DiMauro S. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology. 2001;56:849–55.PubMedGoogle Scholar
  13. 13.
    Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S, Valeriani M, Lynch D, Banwell B, Berg M, Dubrovsky T, Chiriboga C, Angelini C, Pegoraro E, DiMauro S. Cerebellar ataxia and coenzyme CoQ deficiency. Neurology. 2003;60:1206–8.PubMedGoogle Scholar
  14. 14.
    Leshinsky-Silver E, Levine A, Nissenkorn A, Barash V, Perach M, Buzhaker E, Shahmurov M, Polak-Charcon S, Lev D, Lerman-Sagie T. Neonatal liver failure and Leigh syndrome possibly due to CoQ-responsive OXPHOS syndrome. Mol Gen Metab. 2003;79:288–93.CrossRefGoogle Scholar
  15. 15.
    Van Maldergem L, Trijbels F, DiMauro S, Sindelar PJ, Musumeci O, Janssen A, Delberghe X, Martin JJ, Gillerot Y. Coenzyme Q-responsive Leigh’s encephalopathy in two sisters. Ann Neurol. 2002;52:750–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Horvath R, Schneiderat P, Schoser BGH, Gempel K, Neuen-Jacob E, Plöger H, Müller-Höcker J, Pongratz DE, Naini A, DiMauro S, Lochmüller H. Coenzyme Q10 deficiency and isolated myopathy. Neurology. 2006;66:253–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Hirano M, Quinzii CM, DiMauro S. Restoring balance to ataxia with coenzyme Q10 deficiency. J Neurol Sci. 2006;246: 11–12.PubMedCrossRefGoogle Scholar
  18. 18.
    Gironi M, Lamperti C, Nemni R, Moggio M, Comi G, Guerini FR, Ferrante P, Canal N, Naini A, Bresolin N, DiMauro S. Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology. 2004;62: 818–20.PubMedGoogle Scholar
  19. 19.
    Quinzii CM, Kattah BS, Naini A, Akman HO, Mootha VK, DiMauro S, Hirano M. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology. 2005;64:539–41.PubMedGoogle Scholar
  20. 20.
    Artuch R, Brea-Calvo G, Briones P, Aracil A, Galván A, Espinos C, Corral J, Volpini V, Ribes A, Andreu AL, Palau F, Sánchez-Alcázar JA, Navas P, Pineda M. Cerebellar ataxia with coenzyme Q10 deficiency: Diagnosis and follow-up after coenzyme Q10 supplementation. J Neurol Sci. 2006;246: 153–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Boitier E, Degoul F, Desguerre I, Charpentier C, Francois D, Ponsot G, Diry M, Rustin P, Marsac C. A case of mitochondrial encephalomyopathy associated with muscle coenzyme Q10 deficiency. J Neurol Sci. 1998;156:41–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Sobreira C, Hirano M, Shanske S, Haller RG, Davidson E, Santorelli FM, Miranda AF, Bonilla E, Mojon DS, Barreira AA, King MP, DiMauro S. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology. 1997;48:1238–43.PubMedGoogle Scholar
  23. 23.
    Artuch R, Pineda M, Vilaseca MA, Sánchez-Alcázar JA, Navas P. Coenzyme Q10 deficiency and mitochondrial encephalomyopathies: Clinical, biochemical and molecular diagnosis. Ubiquinone-10 supplementation. In: Villaroya F, editor. New frontiers in mitochondrial biogenesis and disease. Kerala, India: Research Signpost, 2005. pp 93–110.Google Scholar
  24. 24.
    Geromel V, Rotig A, Munnich A, Rustin P. Coenzyme Q10 depletion is comparatively less detrimental to human cultured skin fibroblasts than respiratory chain complex deficiencies. Free Radic Res. 2002;36:375–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Naini A, Lewis VJ, Hirano M, DiMauro S. Primary coenzyme CoQ deficiency and the brain. Biofactors. 2003;18:145–52.PubMedGoogle Scholar
  26. 26.
    Trouillas P, Takayanagi T, Hallett M Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timann D, Honnorat J, Nighoghossian N, Manyam B. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997;145:205–11.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Raquel Montero
    • 1
  • Mercé Pineda
    • 2
  • Asun Aracil
    • 2
  • Maria-Antonia Vilaseca
    • 1
  • Paz Briones
    • 3
  • José-Antonio Sánchez-Alcázar
    • 4
  • Plácido Navas
    • 4
  • Rafael Artuch
    • 1
    Email author
  1. 1.Clinical Biochemistry DepartmentHospital Sant Joan de DéuEsplugues, BarcelonaSpain
  2. 2.Neurology DepartmentsHospital Sant Joan de DéuBarcelonaSpain
  3. 3.Institut de Bioquímica Clínica-CSICBarcelona
  4. 4.Centro Andaluz de Biología del DesarrolloUniversidad Pablo de OlavideSevillaSpain

Personalised recommendations